[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Yourgene Health Plc LSE:YGEN London Ordinary Share GB00BN31ZD89 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 14.25 14.00 14.50 - 0.00 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 18.3 -12.0 -1.8 - 103

Yourgene Health Share Discussion Threads

Showing 4201 to 4225 of 4225 messages
Chat Pages: 169  168  167  166  165  164  163  162  161  160  159  158  Older
DateSubjectAuthorDiscuss
16/10/2021
12:01
Just WHEN are we going to ever deliver a sustained and meaningful increase in shareholder value Ngen?Lots of expectations with false starts. And lots of YEARS - heading for 8!!As an investment it's been dismal - hopes always meeting disappointment.There's the trend and it's not a friend!
twix386
15/10/2021
13:02
Impressive results from Boots!And some question marks over a govt lab. Pass it to YGEN!
ngen yap
14/10/2021
22:53
Thanks, got it.
organstop
14/10/2021
15:24
I think the trades around 14.2 yesterday were actually buys - they just appear as sales because they were below the mid price (14.25) when the bid & offer were 14 and 14.5 respectively. LSE and the like don't actually know whether trades are buys or sells, they just assume anything above the mid is a buy and below the mid is a sell.
ikeadave
13/10/2021
22:37
2 days of sells but the share price doesn't drop. Must mean something?
organstop
08/10/2021
18:16
Bang on, hTTps://www.linkedin.com/pulse/open-letter-grant-shapps-tony-cooke/
birdie12
05/10/2021
10:17
I also recently bought a modest top up. Whilst I think the serious growth would have been captured from c.4 or 5p, hindsight is of course a wonderful thing. I liked most of the presentation. Long term I think genetic and reproductive health is going to be a monumental industry and hopefully there is still a lot of growth to come. I can see LR as an empire builder, which I am open to, but not on the back of the scale of dilution they proposed. It’s a funny share though with a curious capacity to disappoint. Possibly some of the genetic code from VIY days is still active. Perhaps ygen could develop a test for that...?
major courtenay
01/10/2021
17:10
bought a top-up at 13.88 this morning. I can resist anything but temptation. The agm presentation has reset my half-empty to half-full.
melton john
30/9/2021
17:18
£15-£16m H1 with momentum building would be surprising if £30m+ wasn't reached at year end and possibly more based on run rate. Lyn will drive hard so FY24 should be achievable imho.
catch007
30/9/2021
16:38
FY24 figures are IMO possible if the DHSC contracts pick up any capacity freed up if/when the private travel business slows. It would be good to see the first US NIPT contract launched and start pulling in revenue too. It sounded like the second US NIPT will be launched in 2022 so probably not material this FY. £25m has to be in the bag this year! Plenty to keep flowing in as the pipeline builds though!
ikeadave
30/9/2021
16:03
hTTps://www.walbrookpr.com/docs/librariesprovider48/default-document-library/investors/ygen---company-summary-(29.09.21).pdf Looks like they might get close to y/e 24 this year?
hjb1
30/9/2021
11:37
Lyn let slip volumes would be around £16m H1 therefore run rate £8m per qtr that would equate to Q3 £24m YTD however this does not take account of hockey stick growth as testing thresholds levels moves well above 100000 as Government lot kicks in. IMHO Q3 total could be £9-10m revenues and Q4 will include NIPT US orders. Though maybe wishful thinking on my part YGEN could be on a trajectory £40m annualised.
catch007
30/9/2021
11:18
Agreed, and if Q3 is as good as Q2, we should be at or around the FY target of £25m by the end of Q3, and that’s before the US Nipt contracts start to ramp up! It’s been a long wait, but maybe the reward for patience is coming!
ikeadave
30/9/2021
10:43
Whilst you have been sleeping I have added a few more today :D Anyone watching the AGM Business Update should be awake to the growing opportunity here!
catch007
30/9/2021
00:20
Wake me up when that's revealed..
admak
29/9/2021
18:45
Catch, it all looks very good over the next few months. Wait until the big US companies are revealed. That will certainly help.
birdie12
29/9/2021
16:51
birdie12: thank you Just watched YGEN AGM update on Investor Meet - excellent progress imho. Looking to top up now on growth potential
catch007
29/9/2021
14:30
20p by easter ??
the monkster
29/9/2021
14:17
Yes ygen supply the actual test and do some of the processing.
birdie12
29/9/2021
13:59
Myhealthchecked results today show doing volume Covid tests with Boots & Lloyds Chemists. I believe YGEN are the lab providers for the tests?
catch007
28/9/2021
17:26
Volumes & revenues starting to ramp up on track for £30m+ full year .....the key metric of course is profitability. We need to see revenue growth create firm net profits in due course to realise the obvious potential.
catch007
28/9/2021
15:22
Good to see the insties putting a block on the bod not allowing them to issue shares whenever they want.
birdie12
28/9/2021
07:54
Yes, if it was purely travel, but hopefully the DHSC contract will be taking over that capacity. More cases than ever at the moment!
ikeadave
28/9/2021
07:51
Decent RNS but mailing 100000 would be a result with the recent changes to travel
best1467
28/9/2021
07:36
Great rns! At least £15m first half, that'll do nicely. Hopefully get near the 200k testing 2nd half for a bumper year.
birdie12
Chat Pages: 169  168  167  166  165  164  163  162  161  160  159  158  Older
ADVFN Advertorial
Your Recent History
LSE
YGEN
Yourgene H..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211018 06:16:19